Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
-94.32%
Change (1 year)
Categories
Earnings for Acorda Therapeutics (ACOR)
Earnings in 2023 (TTM): -$0.27 B
According to Acorda Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.28 B. a decrease over its 2022 earnings that were of -$5.34 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Acorda Therapeutics from 2006 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$0.27 B | 4842.68% |
| 2022 | -$5.34 M | -93.25% |
| 2021 | -$79.04 M | 2.52% |
| 2020 | -$77.1 M | -69.45% |
| 2019 | -$0.26 B | -700.62% |
| 2018 | $42.01 M | -118.02% |
| 2017 | -$0.24 B | 805.99% |
| 2016 | -$25.75 M | -173.88% |
| 2015 | $34.84 M | -6.58% |
| 2014 | $37.29 M | 20.19% |
| 2013 | $31.03 M | 18.7% |
| 2012 | $26.14 M | -26.54% |
| 2011 | $35.58 M | |
| 2009 | -$81.26 M | 10.65% |
| 2008 | -$73.44 M | 86.17% |
| 2007 | -$39.45 M | 68.1% |
| 2006 | -$23.47 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $34.06 M | -112.53% | 🇺🇸 USA |
 Repligen
RGEN | $36.72 M | -113.51% | 🇺🇸 USA |
 Affimed
AFMD | -$0.12 B | -57.73% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $0.23 B | -187.34% | 🇺🇸 USA |